Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06271642 · ClinicalTrials.gov registry record · NA
Impact of Vibrating Device Distraction on Mechanical Pain Thresholds Induced by Needle Sham
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT06271642: Completed NA study, sponsored by Stanford University.
NCT06271642 is a NA study that has completed, run by Stanford University. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06271642, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
This is a prospective, crossover study of healthy participants evaluating the mechanical pain threshold for weighted pinprick stimuli.
Primary Outcome
Mechanical Pain Threshold will be measured using custom-made weighted pinprick stimuli as a set of seven pinprick mechanical stimulators with fixed stimulus intensities (flat contact area of 0.2mm diameter) with forces of 8, 16, 32, 64, 128, 256, and 512mN.
Interventions
- BEHAVIORAL Bluetooth Haptic Device (Experimental Frequency) + Needle Sham only
- BEHAVIORAL Bluetooth Haptic Device (Control Frequency) + Needle Sham only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-06-06 |
| Est. Completion | 2024-07-12 |
| Phase | NA |
What the finished NCT06271642 record still lists
NCT06271642 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Bluetooth Haptic Device (Experimental Frequency) + Needle Sham only is the first listed.
NCT06271642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06271642 about?
NCT06271642 is a clinical study titled "Impact of Vibrating Device Distraction on Mechanical Pain Thresholds Induced by Needle Sham". This is a prospective, crossover study of healthy participants evaluating the mechanical pain threshold for weighted pinprick stimuli.
What is the current status of trial NCT06271642?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2024-06-06. Estimated completion is 2024-07-12.
What interventions are being tested in trial NCT06271642?
The interventions under investigation include: Bluetooth Haptic Device (Experimental Frequency) + Needle Sham only (BEHAVIORAL), Bluetooth Haptic Device (Control Frequency) + Needle Sham only (BEHAVIORAL).
Who is sponsoring clinical trial NCT06271642?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06271642's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI